InflaRx (IFRX) Change in Account Payables (2017 - 2018)

InflaRx's (IFRX) quarterly Change in Account Payables came in at $2.9 million in Q4 2018, down 31.17% year-on-year from $4.2 million in Q4 2017, and up 17.54% quarter-over-quarter from $2.5 million in Q3 2018.

InflaRx (IFRX) Change in Account Payables (2017 - 2018) Analysis & Trends

InflaRx has disclosed Change in Account Payables across 2 years of filings, most recently posting $2.9 million for Q4 2018.

  • Change in Account Payables for Q4 2018 came in at $2.9 million, down 31.17% year-over-year; the trailing twelve-month figure through Dec 2018 was $2.4 million (down 31.58% YoY), and the FY2025 annual result was -$7.0 million, down 1025.67% from the prior year.
  • Change in Account Payables came in at $2.9 million for Q4 2018 at InflaRx, up from $2.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.2 million in Q4 2017 to a low of -$1.9 million in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -3.26 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 35.60 Mn
9 Abivax 94.26 Bn 94.26 Bn - -9.42 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -

Historic Data

Download Data
DateValue
Dec 31, 2018 2.92 Mn
Dec 31, 2018 2.92 Mn
Sep 30, 2018 2.49 Mn
Sep 30, 2018 2.49 Mn
Jun 30, 2018 -1.07 Mn
Jun 30, 2018 -1.07 Mn
Mar 31, 2018 -1.92 Mn
Mar 31, 2018 -1.92 Mn
Dec 31, 2017 4.25 Mn
Dec 31, 2017 4.25 Mn
Sep 30, 2017 271,439.61
Sep 30, 2017 271,439.61
Jun 30, 2017 327,665.70
Jun 30, 2017 327,665.70
Mar 31, 2017 -1.31 Mn
Mar 31, 2017 -1.31 Mn